← Back to directory

Jeffrey A. Morgan

Researcher Next ID · RN-042443

Researcher · Engineering

Sheba Medical Center

Ramat Gan, Israel

Accepting doctoral researchersFunding unknown
Works count
363
Citation count
15,261
H-index
57
i10-index
150

Research interests

Engineering
Medicine
Mechanical Circulatory Support Devices
Cardiac Structural Anomalies and Repair
Transplantation: Methods and Outcomes
Cardiac Arrest and Resuscitation
Gastrointestinal Tumor Research and Treatment

Publications

  • Survival on the Heart Transplant Waiting List

    JAMA Cardiology · 2020 · 10.1001/jamacardio.2020.2795

  • Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

    Cancer · 2017 · 10.1002/cncr.30738

  • Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy

    Annals of Oncology · 2016 · 10.1093/annonc/mdw228

  • Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

    BMC Cancer · 2014 · 10.1186/1471-2407-14-813

  • Impact of continuous-flow left ventricular assist device support on right ventricular function

    The Journal of Heart and Lung Transplantation · 2013 · 10.1016/j.healun.2012.12.018

  • The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary

    The Journal of Heart and Lung Transplantation · 2013 · 10.1016/j.healun.2012.09.013

  • Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

    Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.39.9394

  • Gastrointestinal bleeding with the HeartMate II left ventricular assist device

    The Journal of Heart and Lung Transplantation · 2012 · 10.1016/j.healun.2012.02.015

  • A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

    Annals of Oncology · 2010 · 10.1093/annonc/mdq076

  • Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors

    Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.2981

  • Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors

    Clinical Cancer Research · 2010 · 10.1158/1078-0432.ccr-10-2621

  • Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-0224

  • Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-0482

  • Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

    European Journal of Cancer · 2009 · https://doi.org/10.1016/j.ejca.2009.02.011

  • Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.20.9890

  • A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib

    JNCI Journal of the National Cancer Institute · 2008 · 10.1093/jnci/djm311

  • Leiomyosarcoma of the Inferior Vena Cava: Survival After Aggressive Management

    Annals of Surgical Oncology · 2007 · 10.1245/s10434-007-9552-z

  • Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors

    Clinical Cancer Research · 2007 · 10.1158/1078-0432.ccr-06-0858

  • Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

    The Lancet · 2007 · 10.1016/s0140-6736(07)61865-0

  • Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)69446-4

  • Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

    Annals of Internal Medicine · 2006 · 10.7326/0003-4819-145-9-200611070-00008

  • Surgical Management of Advanced Gastrointestinal Stromal Tumors After Treatment With Targeted Systemic Therapy Using Kinase Inhibitors

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2005.05.3439

  • Does Robotic Technology Make Minimally Invasive Cardiac Surgery Too Expensive? A Hospital Cost Analysis of Robotic and Conventional Techniques

    Journal of Cardiac Surgery · 2005 · 10.1111/j.1540-8191.2005.200385.x

  • Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality

    The Annals of Thoracic Surgery · 2004 · 10.1016/j.athoracsur.2003.09.048

  • Totally Endoscopic Atrial Septal Defect Repair With Robotic Assistance

    Circulation · 2003 · 10.1161/01.cir.0000089043.82199.2f

Current projects

    No projects listed.